Last week, the United States Department of Justice issued an order moving FDA-approved marijuana products, as well as state-licensed medical marijuana products, to Schedule III of the Controlled Substances Act (CSA), implementing President Trump’s December 18, 2025, Executive Order.
| less than a minute read
Cannabis Rescheduling: What Does It Mean for Your Intellectual Property
/Passle/684c7d72fa5dee4bb58c5944/SearchServiceImages/2026-07-23-16-01-22-862-6a623ad2340ea8a638d59559.jpg)
/Passle/684c7d72fa5dee4bb58c5944/SearchServiceImages/2026-07-22-17-28-30-230-6a60fdbee61f23f448cc1810.jpg)
/Passle/684c7d72fa5dee4bb58c5944/SearchServiceImages/2026-07-06-18-07-59-962-6a4beeffb91fcc5788ea2637.jpg)
/Passle/684c7d72fa5dee4bb58c5944/SearchServiceImages/2026-07-06-18-06-21-303-6a4bee9db62975e4c00500f5.jpg)